Relative cost of multidrug-resistant TB medicines in Europe

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The international journal of tuberculosis and lung disease 2023-05, Vol.27 (5), p.341-344
Hauptverfasser:	Günther, G., Guglielmetti, L., Leu, C., van Leth, F., Lange, C.
Format:	Artikel
Sprache:	eng
Schlagworte:	Antitubercular Agents - therapeutic use Drug resistance Europe Humans Multidrug resistance Tuberculosis, Multidrug-Resistant - drug therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	344
container_issue	5
container_start_page	341
container_title	The international journal of tuberculosis and lung disease
container_volume	27
creator	Günther, G. Guglielmetti, L. Leu, C. van Leth, F. Lange, C.
description
doi_str_mv	10.5588/ijtld.23.0026
format	Article
fullrecord	<record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_journals_2817790459</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><ingid>iuatld/ijtld/2023/00000027/00000005/art00001</ingid><sourcerecordid>2817790459</sourcerecordid><originalsourceid>FETCH-LOGICAL-c494t-7a47dbc3cf0738912b88238cb92c4c4481eadd5fc54ae61d222b95810b4429793</originalsourceid><addsrcrecordid>eNp1kU1rGzEQhkVIyVd77LUs5JLLutJIsiR6ymcbCCQU9yy0Wq2RWe-6kjaQ_vpItttCILpoGB6eGd5B6DPBM86l_OpXqW9nQGcYw_wAnRBJeC0U4MNcYxA1FUQdo9MYV5kghIgjdJx7jAIlJ-jbT9eb5J9dZceYqrGr1lOffBumZR1c9DGZIVWLq2rtWm_94GLlh-p2CuPGfUQfOtNH92n_n6Ffd7eL6x_1w-P3--vLh9oyxVItDBNtY6ntsKBSEWikBCpto8Ayy5gkzrQt7yxnxs1JCwCN4pLghjFQQtEzdLHzbsL4e3Ix6bWP1vW9Gdw4RQ2ZVURmUUbP36CrcQpD3q5QQijMeBHWO8qGMcbgOr0Jfm3CiyZYl1T1NlUNVJdUM_9lb52anMM_-m-MGXjaAX5YuiGZ_1O91X4yRVaOUW6hn0EMXAMGiudlAqNCt64zOXedTNDLPzoW5c17yp1vvyLeLlkeiH2BuTYhlYLQV7FtokM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2817790459</pqid></control><display><type>article</type><title>Relative cost of multidrug-resistant TB medicines in Europe</title><source>MEDLINE</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Günther, G. ; Guglielmetti, L. ; Leu, C. ; van Leth, F. ; Lange, C.</creator><creatorcontrib>Günther, G. ; Guglielmetti, L. ; Leu, C. ; van Leth, F. ; Lange, C.</creatorcontrib><identifier>ISSN: 1027-3719</identifier><identifier>EISSN: 1815-7920</identifier><identifier>DOI: 10.5588/ijtld.23.0026</identifier><identifier>PMID: 37143231</identifier><language>eng</language><publisher>France: International Union Against Tuberculosis and Lung Disease</publisher><subject>Antitubercular Agents - therapeutic use ; Drug resistance ; Europe ; Humans ; Multidrug resistance ; Tuberculosis, Multidrug-Resistant - drug therapy</subject><ispartof>The international journal of tuberculosis and lung disease, 2023-05, Vol.27 (5), p.341-344</ispartof><rights>Copyright International Union against Tuberculosis and Lung Disease (IUATLD) 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c494t-7a47dbc3cf0738912b88238cb92c4c4481eadd5fc54ae61d222b95810b4429793</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37143231$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Günther, G.</creatorcontrib><creatorcontrib>Guglielmetti, L.</creatorcontrib><creatorcontrib>Leu, C.</creatorcontrib><creatorcontrib>van Leth, F.</creatorcontrib><creatorcontrib>Lange, C.</creatorcontrib><title>Relative cost of multidrug-resistant TB medicines in Europe</title><title>The international journal of tuberculosis and lung disease</title><addtitle>Int J Tuberc Lung Dis</addtitle><subject>Antitubercular Agents - therapeutic use</subject><subject>Drug resistance</subject><subject>Europe</subject><subject>Humans</subject><subject>Multidrug resistance</subject><subject>Tuberculosis, Multidrug-Resistant - drug therapy</subject><issn>1027-3719</issn><issn>1815-7920</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kU1rGzEQhkVIyVd77LUs5JLLutJIsiR6ymcbCCQU9yy0Wq2RWe-6kjaQ_vpItttCILpoGB6eGd5B6DPBM86l_OpXqW9nQGcYw_wAnRBJeC0U4MNcYxA1FUQdo9MYV5kghIgjdJx7jAIlJ-jbT9eb5J9dZceYqrGr1lOffBumZR1c9DGZIVWLq2rtWm_94GLlh-p2CuPGfUQfOtNH92n_n6Ffd7eL6x_1w-P3--vLh9oyxVItDBNtY6ntsKBSEWikBCpto8Ayy5gkzrQt7yxnxs1JCwCN4pLghjFQQtEzdLHzbsL4e3Ix6bWP1vW9Gdw4RQ2ZVURmUUbP36CrcQpD3q5QQijMeBHWO8qGMcbgOr0Jfm3CiyZYl1T1NlUNVJdUM_9lb52anMM_-m-MGXjaAX5YuiGZ_1O91X4yRVaOUW6hn0EMXAMGiudlAqNCt64zOXedTNDLPzoW5c17yp1vvyLeLlkeiH2BuTYhlYLQV7FtokM</recordid><startdate>20230501</startdate><enddate>20230501</enddate><creator>Günther, G.</creator><creator>Guglielmetti, L.</creator><creator>Leu, C.</creator><creator>van Leth, F.</creator><creator>Lange, C.</creator><general>International Union Against Tuberculosis and Lung Disease</general><general>International Union against Tuberculosis and Lung Disease (IUATLD)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7U7</scope><scope>7U9</scope><scope>C1K</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>20230501</creationdate><title>Relative cost of multidrug-resistant TB medicines in Europe</title><author>Günther, G. ; Guglielmetti, L. ; Leu, C. ; van Leth, F. ; Lange, C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c494t-7a47dbc3cf0738912b88238cb92c4c4481eadd5fc54ae61d222b95810b4429793</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Antitubercular Agents - therapeutic use</topic><topic>Drug resistance</topic><topic>Europe</topic><topic>Humans</topic><topic>Multidrug resistance</topic><topic>Tuberculosis, Multidrug-Resistant - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Günther, G.</creatorcontrib><creatorcontrib>Guglielmetti, L.</creatorcontrib><creatorcontrib>Leu, C.</creatorcontrib><creatorcontrib>van Leth, F.</creatorcontrib><creatorcontrib>Lange, C.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>The international journal of tuberculosis and lung disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Günther, G.</au><au>Guglielmetti, L.</au><au>Leu, C.</au><au>van Leth, F.</au><au>Lange, C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Relative cost of multidrug-resistant TB medicines in Europe</atitle><jtitle>The international journal of tuberculosis and lung disease</jtitle><addtitle>Int J Tuberc Lung Dis</addtitle><date>2023-05-01</date><risdate>2023</risdate><volume>27</volume><issue>5</issue><spage>341</spage><epage>344</epage><pages>341-344</pages><issn>1027-3719</issn><eissn>1815-7920</eissn><cop>France</cop><pub>International Union Against Tuberculosis and Lung Disease</pub><pmid>37143231</pmid><doi>10.5588/ijtld.23.0026</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext	fulltext
identifier	ISSN: 1027-3719
ispartof	The international journal of tuberculosis and lung disease, 2023-05, Vol.27 (5), p.341-344
issn	1027-3719 1815-7920
language	eng
recordid	cdi_proquest_journals_2817790459
source	MEDLINE; PubMed Central; Alma/SFX Local Collection
subjects	Antitubercular Agents - therapeutic use Drug resistance Europe Humans Multidrug resistance Tuberculosis, Multidrug-Resistant - drug therapy
title	Relative cost of multidrug-resistant TB medicines in Europe
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T17%3A39%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Relative%20cost%20of%20multidrug-resistant%20TB%20medicines%20in%20Europe&rft.jtitle=The%20international%20journal%20of%20tuberculosis%20and%20lung%20disease&rft.au=G%C3%BCnther,%20G.&rft.date=2023-05-01&rft.volume=27&rft.issue=5&rft.spage=341&rft.epage=344&rft.pages=341-344&rft.issn=1027-3719&rft.eissn=1815-7920&rft_id=info:doi/10.5588/ijtld.23.0026&rft_dat=%3Cproquest_pubme%3E2817790459%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2817790459&rft_id=info:pmid/37143231&rft_ingid=iuatld/ijtld/2023/00000027/00000005/art00001&rfr_iscdi=true